Discontinuing donepezil or starting memantine for Alzheimer's disease

New England Journal of Medicine

Volumn 366, Issue 10, 2012, Pages 957-959

  Schneider, Lon S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; MEMANTINE;

ADD ON THERAPY; ALZHEIMER DISEASE; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; EDITORIAL; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 84857848793     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1200429     Document Type: Editorial

References (9)

1. Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2006;1:CD001190.
2. Gill SS, Anderson GM, Fischer HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med 2009;169:867-73.
3. Herrmann N, Black SE, Li A, Lanctôt KL. Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts. Int Psychogeriatr 2011;23:539-45.
4. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease: review of NICE technology appraisal guidance 111. London: National Institute for Health and Clinical Excellence, 2011 (http://www.nice. org.uk/nicemedia/ live/13419/53619/53619.pdf).
5. Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012;366:893-903.
6. Holmes C, Wilkinson D, Dean C, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004;63:214-9. (Pubitemid 38971117)
7. Darreh-Shori T, Soininen H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. Curr Alzheimer Res 2010;7:67-73.
8. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev 2006;2:CD003154.
9. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004;291:317-24. (Pubitemid 38101604)